Report

Global Pancreatic and Biliary Stents Market Size study, by Product Type (Plastic Stents, Metal Stents Bovine), by Application (Benign Biliary strictures, Bilio-pancreatic leakages, Pancreatic Cancer, Others), by End use (Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Global Pancreatic and Biliary Stents Market to reach USD XX billion by 2027.Global Pancreatic and Biliary Stents Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.05% over the forecast period 2021-2027. A pancreatic and biliary stent is a tubular device made of plastic or metal that is put into a lumen or duct in the human body to keep the bile or pancreatic duct route open. Stents can also be used to treat biliary/pancreatic leakage and avoid pancreatitis after an ERCP procedure. The rise in the number of prostate cancer cases around the world has assisted the expansion of pancreatic stents, which has boosted demand for metal stents. Patients with unresectable pancreatic cancer have had a higher life expectancy in recent years, which has raised demand for stenting procedures. The pancreatic and biliary market has benefited from the introduction of new products and the advancement of technology. Cook Medical introduced the Zilver 635 Biliary Self-Expanding Stents for biliary SEMS treatments in December 2019. In addition, the pancreatic and biliary stents market has grown, owing to a growing desire for minimally invasive operations and an increase in the global elderly population. According to the United Nations, the global share of persons aged 65 and more is 9% in 2019 and is anticipated to rise to 16% by 2050. In 2019, According to a World Health Organization report, the population of adults aged 60 and up totaled one billion. By 2050, this number is predicted to rise to 2.1 billion. In 2020, there were 495,773 new cases of pancreatic cancer worldwide. By 2025, this number is predicted to rise to 564,930. Due to the advent of the COVID-19 pandemic in 2019, there has been a huge shift in the market. Because most gastrointestinal treatments were postponed during the pandemic, the number of ERCP and PTC procedures for pancreatic and biliary stenting decreased. Endoscopic cancer detection decreased by 58 percent overall in 2020, according to a study published in BMJ Journals- United Kingdom's National Endoscopy Database (NED). A decline in cancer detection has resulted in a reduction in pancreatic cancer surgical procedures. As a result, during the pandemic, the whole market for pancreatic and biliary stents was impacted. The market, on the other hand, is likely to recover from the setback over time. However, concerns regarding the high cost associated with procedural complexities may impede market growth over the forecast period of 2021-2027.

The regional analysis of the Global Pancreatic and Biliary Stents Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to a well-established healthcare industry and rising prevalence of chronic diseases in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increasing population of people suffering from pancreatic cancer.

Major market player included in this report are:

Boston Scientific Corporation
Cook Medical Inc
CONMED Corporation
Olympus Corporation
Becton, Dickinson and Company
Abbott Laboratories
Medtronic Plc
Stryker Corporation
Taewoong Medical Co., Ltd.
B. Braun Melsungen AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Plastic Stents
Metal Stents Bovine
By Application:
Benign Biliary strictures
Bilio-pancreatic leakages
Pancreatic Cancer
Others
By End use:
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year -2018,2019
Base year -2020
Forecast period - 2021 to 2027.

Target Audience of the Global Pancreatic and Biliary Stents Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors